Form 4: Rallybio Corp Director Wendy Chung Acquires Options

Director Wendy Chung acquired options to purchase 28,500 shares of Rallybio Corp common stock on May 13, 2025.

Summary

• Wendy Chung, a director of Rallybio Corp, filed a Form 4 on May 15, 2025, reporting a transaction.
• On May 13, 2025, Chung acquired options to purchase 28,500 shares of Rallybio Corp common stock at an exercise price of $0.30.
• The options were granted under the company's 2021 Equity Incentive Plan and vest on the earlier of May 13, 2026, or the date of the company's 2026 Annual Meeting of Stockholders.
• Following the transaction, Chung directly owns 28,500 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard Form 4 filing indicating a director's acquisition of options, which could be seen as a positive sign but doesn't provide definitive information about the company's performance.

Positives

• The acquisition of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Rallybio Corp, Director, Options, Wendy Chung, Equity Incentive Plan, Beneficial Ownership